ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 258 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,534,000 | +211.2% | 16,502 | +99.3% | 0.01% | +50.0% |
| Q3 2021 | $493,000 | -18.5% | 8,282 | -6.7% | 0.00% | -20.0% |
| Q2 2021 | $605,000 | +74.9% | 8,873 | +78.1% | 0.01% | -61.5% |
| Q1 2021 | $346,000 | -16.0% | 4,982 | -7.1% | 0.01% | -18.8% |
| Q4 2020 | $412,000 | +3.0% | 5,364 | +0.2% | 0.02% | -5.9% |
| Q3 2020 | $400,000 | +22.3% | 5,351 | +3.0% | 0.02% | +13.3% |
| Q2 2020 | $327,000 | -11.4% | 5,197 | -40.8% | 0.02% | +66.7% |
| Q1 2020 | $369,000 | -10.2% | 8,783 | -3.0% | 0.01% | +12.5% |
| Q4 2019 | $411,000 | +5.4% | 9,058 | +6.3% | 0.01% | 0.0% |
| Q3 2019 | $390,000 | -22.9% | 8,524 | -1.3% | 0.01% | -33.3% |
| Q2 2019 | $506,000 | +52.4% | 8,635 | +16.6% | 0.01% | +50.0% |
| Q1 2019 | $332,000 | +19.9% | 7,406 | +4.1% | 0.01% | 0.0% |
| Q4 2018 | $277,000 | -14.2% | 7,114 | -3.9% | 0.01% | 0.0% |
| Q2 2018 | $323,000 | +43.6% | 7,406 | +30.1% | 0.01% | +33.3% |
| Q1 2018 | $225,000 | – | 5,694 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |